Patient-derived high functional avidity TCR empowers diverse T cell subsets for tumour immunotherapy
Cancer-testis antigens (CTAs) are attractive targets for tumour immunotherapy due to their restricted expression in human malignancies and broad population-level prevalence. However, naturally occurring CTA-reactive T cells are often exhausted or funct…